1. The long-term efficacy and tolerability of oral deferasirox for patients with transfusion-dependent β-thalassemia in Taiwan

   • Hsiu-Hao Chang
   • Meng-Yao Lu
   • Kai-Hsin Lin

   Original Article Open access 25 September 2015 Pages: 1945 - 1952

   

2. Diverse phenotypes and transfusion requirements due to interaction of β-thalassemias with triplicated α-globin genes

   • Pallavi R. Mehta
   • Dipti S. Upadhye
   • Roshan B. Colah

   Original Article 29 August 2015 Pages: 1953 - 1958

3. Early postnatal diagnosis of hereditary spherocytosis by combining light microscopy, acidified glycerol lysis test and eosin-5′-maleimide binding assay

   • Oliver Andres
   • Stefan Eber
   • Christian P. Speer

   Original Article 04 September 2015 Pages: 1959 - 1964

   

4. Association of GSTM1 and GSTT1 deletion polymorphisms with Pakistani aplastic anemia patients and controls and meta-analysis

   • Sadia Rehman
   • Parvez Ahmed
   • Atika Mansoor

   Original Article 01 September 2015 Pages: 1965 - 1971

   

5. Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥65 years with immune thrombocytopenia

   • Marc Michel
   • Jeffrey Wasser
   • Xuena Wang

   Original Article 04 September 2015 Pages: 1973 - 1980

6. Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013)

   • Theo de Witte
   • Stefan Suciu
   • Frédéric Baron

   Original Article Open access 26 September 2015 Pages: 1981 - 1989

   

7. Evaluation of IDH1G105 polymorphism as prognostic marker in intermediate-risk AML

   • Annette Fasan
   • Claudia Haferlach
   • Susanne Schnittger

   Original Article 09 September 2015 Pages: 1991 - 2001

   

8. Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG)

   • Heiko Becker
   • Stefan Suciu
   • Michael Lübbert

   Original Article 24 September 2015 Pages: 2003 - 2013

   

9. Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML

   • Alice Fabarius
   • Lida Kalmanti
   • for the SAKK and the German CML Study Group

   Original Article 18 September 2015 Pages: 2015 - 2024

   

10. Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings

    • Myron S. Czuczman
    • A. Goy
    • R. H. van der Jagt

    Original Article 28 September 2015 Pages: 2025 - 2032

    

11. Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience

    • Eirini Katodritou
    • Evangelos Terpos
    • Meletios-Athanasios Dimopoulos

    Original Article 30 September 2015 Pages: 2033 - 2042

    

12. Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma

    • Nobuhiko Nakamura
    • Takeshi Hara
    • Hisashi Tsurumi

    Original Article 19 September 2015 Pages: 2043 - 2053

    

13. Clinical impact of hematogones on outcomes of allogeneic hematopoietic stem cell transplantation

    • Noriko Doki
    • Kyoko Haraguchi
    • Kazuteru Ohashi

    Original Article 04 September 2015 Pages: 2055 - 2060

    

14. Late occurrence of Epstein-Barr virus-associated lymphoproliferative disorder in a patient with follicular lymphoma treated with bendamustine and rituximab

    • Kei Muroi
    • Mamiko Sakata-Yanagimoto
    • Shigeru Chiba

    Letter to the Editor 04 August 2015 Pages: 2061 - 2062

    

15. Lower gastrointestinal bleeding in a patient with Crohn’s disease and plasma cell leukemia in remission

    • Karin G. Schrenk
    • Kathrin Katenkamp
    • Sebastian Scholl

    Letter to the Editor 21 August 2015 Pages: 2063 - 2065

    

16. Hyperleukocytosis in acute myeloid leukemia patients is associated with high 30-day mortality which is not improved with leukapheresis

    • Gee Chuan Wong

    Letter to the Editor 09 August 2015 Pages: 2067 - 2068

17. Low levels of CD9 coincidental with a novel nonsense mutation in glycoprotein Ibβ in a patient with Bernard-Soulier syndrome

    • Jianlin Qiao
    • Amanda K. Davis
    • Robert K. Andrews

    Letter to the Editor 16 August 2015 Pages: 2069 - 2071

    

18. Oral beclomethasone dipropionate as an initial treatment for stages 1–2 gastrointestinal tract acute graft-versus-host disease following unrelated cord blood transplantation

    • Hisashi Yamamoto
    • Naoyuki Uchida
    • Shuichi Taniguchi

    Letter to the Editor 16 September 2015 Pages: 2073 - 2075

19. Safe utilization of ibrutinib with or without steroids in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia

    • Rosanne St. Bernard
    • Cyrus C. Hsia

    Letter to the Editor 03 September 2015 Pages: 2077 - 2079

20. Enhanced formation of neutrophil extracellular traps in patients with graft versus host disease

    • Jianlin Qiao
    • Feng Zhu
    • Lingyu Zeng

    Letter to the Editor 07 September 2015 Pages: 2081 - 2083